News

The sale, valued at about $576.5 million, is part of Rite Aid’s restructuring plan after filing for bankruptcy in October 2023.

Should site-neutral payment rules and policies be extended to commercial payers, payment for physician-administered drugs, and services delivered in on-campus hospital outpatient departments?

Study authors hypothesized that factors such as depression, IBD medications, and stomach or rectal surgery may play a role in the increased risk of erectile dysfunction in patients with IBD.

New research finds that in 2022, U.S. prices across all drugs were almost three times higher than in other countries.

Risk also increases with age.

Biogen has stopped its confirmatory trial of Aduhelm and will direct resources toward Leqembi and the research of other treatments for Alzheimer’s disease.

ART-related weight gain is a relatively new phenomenon even though ART has been around for nearly 30 years.

Once the transaction is complete in the first quarter of 2025, Evernorth Health Services will continue to provide pharmacy benefit services to the Medicare businesses.

The report on drug spending touches on the rise of the GLP-1s. hows that As of January, semaglutide was the 5th ranked drug when it came to drug expenditures among Vizient pharmacy partners.

CMS said in a news release today that 13.7 million beneficiaries are in accountable care organizations (ACOs) and that a total of 480 ACOs are participating in the Medicare Shared Savings Program (MSSP).

CVS Caremark, however, will continue to manage specialty drug benefits for Tyson Foods.

Data from 17 longitudinal studies of adults with HIV treated with antiretroviral therapy how that proportion of deaths caused by AIDS has fallen from nearly 50% to 16% and that all-cause mortality has been sliced in half.

Adherent patients accessed services only slightly more.

After the overturn of Roe V. Wade, states with ban see less than a dozen legal abortions a month.

The FDA orders new warnings for CAR-T cell therapies due to reports of T-cell malignancies, including fatal cases, applying to BCMA- and CD19-directed genetically modified autologous T-cell immunotherapies.

Gilead's share price fell 10% today after it announced that Trodelvy, an antibody-drug conjugate, failed to meet its overall survival end point in a trial testing it as treatment for metatstatic non-small cell lung cancer.

Experts from Harvard, Georgetown and Johns Hopkins debate the wisdom of cost sharing in today's JAMA Internal Medicine.

A research team led by University of California, San Francisco, found flaws in how the large language model assessed prevalence and made differential diagnoses.

The FDA approved Dermavant Science's Vtama (tapinarof cream) last year as a treatment for plaque psoriasis. Sales have been disappointing, according to press reports. Will Vtama, which has a different mechanism of action than the current batch of topical medications for atopic dermatitis, fare better in the atopic dermatitis market?

The outlook for leukemia patients improved after Gleevec (imatinib) was approved in 2001 as a treatment for chronic myeloid leukemia. The American Cancer Society published its annual cancer statistics report today that projects 62,770 new cases of leukemia will be diagnosed this year and 23,670 deaths from the disease will occur.

Annual report from the American Cancer Society says HIV is an underlying factor in a handful of cancer diagnoses.

The proportion of cancer patients who are 50-64 is increasing while the proportion of those 65 and older is shrinking, according to American Cancer Society researchers.

Overall cancer mortality in the U.S. continues to decline but there are some worrying trends in incidence and wide racial disparities.